FIPB approves Sun Pharma issuing shares to non-resident investors


(Photo Courtesy:

With reference to earlier announcement dated November 24, 2014 regarding updates on Scheme of Arrangement, Sun Pharmaceutical has informed further to Bombay Stock Exchange (BSE) that Foreign Investment Promotion Board (FIPB) has approved its proposal for issuing its equity shares to the non-resident investors of Ranbaxy Laboratories pursuant to the merger of Ranbaxy Laboratories into Sun Pharmaceutical Industries through the scheme of arrangement between Ranbaxy Laboratories and Sun Pharmaceutical Industries.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email